CAPTRUST Financial Advisors
CRBP icon

CAPTRUST Financial Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25
Closed – – 2465
2022
Q2 		$0 Hold
25
– – ﹤0.01% 4956
2022
Q1 		$0 Hold
25
– – ﹤0.01% 4943
2021
Q4 		$0 Buy
25
+8
+47% +$217 ﹤0.01% 4783
2021
Q3 		$1K Hold
17
– – ﹤0.01% 4410
2021
Q2 		$1K Sell
17
-8
-32% -$444 ﹤0.01% 4316
2021
Q1 		$1K Hold
25
– – ﹤0.01% 4175
2020
Q4 		$1K Hold
25
– – ﹤0.01% 3238
2020
Q3 		$1K Buy
25
+8
+47% +$1.45K ﹤0.01% 2883
2020
Q2 		$4K Buy
+17
New +$3.44K ﹤0.01% 2431
2018
Q3 		– Sell
-83
Closed -$13K – 1586
2018
Q2 		$13K Buy
+83
New +$15.1K ﹤0.01% 1083

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAPTRUST Financial Advisors's CRBP Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Corbus Pharmaceuticals (CRBP) in Q3 2022, closing a stake of 25 shares.

CAPTRUST Financial Advisors first reported a position in CRBP in Q2 2018 and held it in 10 quarters. The position peaked at $13K in Q2 2018. 64 funds tracked by Wall St. Rank hold CRBP as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Corbus Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 25 Corbus Pharmaceuticals shares in Q3 2022.
  • CAPTRUST Financial Advisors first reported a position in Corbus Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • CAPTRUST Financial Advisors's Corbus Pharmaceuticals position peaked at $13K in Q2 2018.
  • 64 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.